1. A Novel Mechanism to Drive Castration-Resistant Prostate Cancer. (June 2018) Authors: Kaochar, Salma; Mitsiades, Nicholas Journal: Trends in endocrinology and metabolism Issue: Volume 29:Number 6(2018) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer. Issue 1 (January 2012) Authors: Bedoya, Diego J; Mitsiades, Nicholas Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 1(2012) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer. Issue 1 (January 2012) Authors: Bedoya, Diego J; Mitsiades, Nicholas Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 1(2012) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer. Issue 8 (15th July 2021) Authors: Mitsiades, Nicholas; Kaochar, Salma Journal: Endocrine-related cancer Issue: Volume 28:Issue 8(2021) Page Start: T19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhibition of GATA2 in prostate cancer by a clinically available small molecule. Issue 1 (24th November 2021) Authors: Kaochar, Salma; Rusin, Aleksandra; Foley, Christopher; Rajapakshe, Kimal; Robertson, Matthew; Skapura, Darlene; Mason, Cammy; Berman De Ruiz, Karen; Tyryshkin, Alexey Mikhailovich; Deng, Jenny; Shin, Jin Na; Fiskus, Warren; Dong, Jianrong; Huang, Shixia; Navone, Nora M; Davis, Christel M; Ehli, E... Journal: Endocrine-related cancer Issue: Volume 29:Issue 1(2022) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery. Issue 2 (22nd April 2022) Authors: Koc, Soner; Lloyd, Michael W; Grover, Jeffrey W; Xiao, Nan; Seepo, Sara; Subramanian, Sai Lakshmi; Ray, Manisha; Frech, Christian; DiGiovanna, John; Webster, Phillip; Neuhauser, Steven; Srivastava, Anuj; Woo, Xing Yi; Sanderson, Brian J; White, Brian; Lott, Paul; Dobrolecki, L... Journal: NAR cancer Issue: Volumer 4:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. (28th January 2017) Authors: Wu, Fei; Dai, Xiangpeng; Gan, Wenjian; Wan, Lixin; Li, Min; Mitsiades, Nicholas; Wei, Wenyi; Ding, Qiang; Zhang, Jinfang Journal: Cancer letters Issue: Volume 385(2017) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics. (10th April 2022) Authors: Lowder, Dallin; Rizwan, Kinza; McColl, Collin; Paparella, Alyssa; Ittmann, Michael; Mitsiades, Nicholas; Kaochar, Salma Journal: Cancer letters Issue: Volume 531(2022) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗